Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma

Cancer

Volumn 88, Issue 5, 2000, Pages 1016-1024

  Kubo, Shoji ^a   Hirohashi, Kazuhiro ^a   Tanaka, Hiromu ^a   Tsukamoto, Tadashi ^a   Shuto, Taichi ^a   Yamamoto, Takatsugu ^a   Ikebe, Takashi ^a   Wakasa, Kenichi ^b   Nishiguchi, Shuhei ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Liver resection; Precore mutant type hepatitis B virus; Wild type hepatitis B virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL RATE; THROMBOCYTE COUNT; VIRUS LOAD;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; HEPATECTOMY; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; VIRAL LOAD;

EID: 0034162471     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V     Document Type: Article

References (45)

1. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35:828-82.
2. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991;14:802-5.
3. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-7.
4. Jwo S-C, Chiu J-H, Chau G-Y, Loong C-C, Lui W-Y. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992;16:1367-71.
5. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488-94.
6. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25.
7. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S, et al. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993;40:328-32.
8. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106:1618-24.
9. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106:720-7.
10. Di Carlo V, Ferrari G, Castoldi R, Nadalin S, Marenghi C, Molteni B, et al. Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics. Hepatogastroenterology 1995;42:222-9.
11. Ng IOL, Lai ECS, Fan ST, Ng MMT, So MKP. Prognostic significance of pathologic features of hepatocellular carcinoma: a multivariate analysis of 278 patients. Cancer 1995; 76:2443-8.
12. Fuster J, Garc'a-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, et al. Hepatocellular carcinoma and cirrhosis: results of surgical treatment in a European series. Ann Surg 1996;223:297-302.
13. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P, et al. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998;82:1028-36.
14. Shirabe K, Takenaka K, Taketomi A, Kawahara N, Yamamoto K, Shimada M, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996;77: 1050-5.
15. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy: result of multivariate analysis. Ann Surg 1996; 224:591-5.
16. Kubo S, Kinoshita H, Hirohashi K, Tanaka H, Shuto T, Okuda T, et al. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Hepatogastroenterology 1999;46:3212-5.
17. Kubo S, Nishiguchi S, Shuto T, Tanaka H, Tsukamoto T, Hirohashi K, et al. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma. Jpn J Cancer Res 1999;90:162-70.
18. Sherlock S, Dooley J. Diseases of the liver and biliary system. 10th edition. Oxford: Blackwell Science Ltd., 1997.
19. Lok ASF, Lai C-L. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection: incidence, predisposing factors and etiology. J Hepatol 1990;10:29-34.
20. Brunetto MR, Giarin M, Saracco G, Oliveri F, Calvo P, Capra G, et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993;105:845-50.
21. Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology 1995;21:1492-9.
22. Makuuchi M, Hasegawa S, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985;161: 346-50.
23. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma on chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5.
24. Minamitani S, Nishiguchi S, Kuroki T, Otani S, Monna T. Detection by ligase chain reaction of precore mutant of hepatitis B virus. Hepatology 1997;25:216-22.
25. Hendricks DA, Stowe BJ, Hoo BS, Kolberg J, Irvine BD, Neuwald PD, et al. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995;104:537-46.
26. Brunetto MR, Randone A, Ranki M, Jalanko A, Piantino P, Giarin M, et al. Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay. J Med Virol 1994;43:310-5.
27. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462-503.
28. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 3rd edition. Tokyo: Kanehara, 1992.
29. Tsuda H, Oda T, Sakamoto M, Hirohashi S. Diffrent pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their mulitfocal origin. Cancer Res 1992;52:1504-9.
30. Okuda K, Tanaka M, Nakayama T, Saitsu H, Tanikawa K, Nakashima O, et al. Clinicopathologic comparison between resected hepatocellular carcinoma (HCC) and recurrent tumors: a special reference to multicentric carcinogenesis of HCC. Int Hepatol Commun 1993;1:65-71.
31. Takenaka K, Adachi E, Nishizaki T, Hiroshige K, Ikeda T, Tsuneyoshi M, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology 1994;19:889-94.
32. Kubo S, Nishiguchi S, Hirohashi K, Shuto T, Kuroki T, Minamitani S, et al. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. Jpn J Cancer Res 1998;89:419-26.
33. Kumada T, Nakano S, Takaeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997;25:87-92.
34. Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996;77:2022-31.
35. Knodell RG, Ishak KG, Black WC, Chen TS, Crag R, Kaplowitz N, et al. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
36. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
37. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathological features and results of surgical treatment. Ann Surg 1990;211:277-87.
38. Pugh RNH, Murray-Lyon HO, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
39. Volpes R, van den Oord JJ, Desmet VJ. Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992;15:269-75.
40. Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990;12:59-65.
41. Chen P-J, Chen D-S, Lai M-Y, Chang M-H, Huang G-T, Yang P-M, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology 1989;96:527-9.
42. Sakamoto M, Hirohashi S, Tsuda H, Shimosato Y, Makuuchi M, Hosoda Y. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J Surg Pathol 1989;13:1064-7.
43. Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El-Assai ON. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turucotte class B and C cirrhosis. Ann Surg 1999;229:84-90.
44. Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Ikebe T, et al. Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. World J Surg. In press.
45. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-703.